Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)
Clinical trial NCT04773600 · COMPLETED
Trial details
- NCT number
- NCT04773600
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2022-09-29
- Enrollment
- 683
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.